Hood River Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$25.6M	Buy	888,470 +15,835	+2%	+$455K	0.36%	94
2025 Q1	$29.3M	Buy	872,635 +21,235	+2%	+$712K	0.5%	80
2024 Q4	$43.5M	Buy	851,400 +16,488	+2%	+$843K	0.64%	64
2024 Q3	$42.7M	Buy	834,912 +424,570	+103%	+$21.7M	0.69%	58
2024 Q2	$18.4M	Buy	+410,342	New	+$18.4M	0.38%	85